CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $88.32, marking a +0.73% move from the previous day.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $87.68, marking a +0.18% move from the previous day.
Here's Why You Should Hold on to Walgreens Boots (WBA) for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA) given its better-than-expected fourth-quarter fiscal 2021 results and strategic alliances.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $84.48, marking a -1.58% move from the previous day.
NextGen's (NXGN) Integrated Platform Gets Leveraged by Mednax
by Zacks Equity Research
Mednax utilizes NextGen's (NXGN) fully-integrated platform to enhance its efficacy in placing crucial information on patients' health and well-being at the physician's fingertips.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is CVS Health (CVS) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Is (CVS) Outperforming Other Retail-Wholesale Stocks This Year?
CVS Health (CVS) Stock Moves -0.11%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $84.28, moving -0.11% from the previous trading session.
Quidel Corporation (QDEL) Reports Solid Preliminary Q3 Revenues
by Zacks Equity Research
Quidel's (QDEL) revenue growth in the third quarter is likely to have been boosted by robust sales of its SARS-related products.
Top Analyst Reports for Pfizer, American Tower & Intuitive Surgical
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), American Tower Corporation (AMT), and Intuitive Surgical, Inc. (ISRG).
CVS Health (CVS) Stock Moves -0.31%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $83.81 in the latest trading session, marking a -0.31% move from the prior day.
Here's Why You Should Retain CVS Health (CVS) Stock For Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on growth in the company's specialty digital solutions and a bullish 2021 outlook.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $85.74 in the latest trading session, marking a +1.22% move from the prior day.
CVS Health (CVS) Retail Business Grows Despite Cost Pressure
by Zacks Equity Research
CVS Health's (CVS) retail business sees solid rebound in front-store sales with strength across all categories.
The Zacks Analyst Blog Highlights: United Parcel Service, ServiceNow, CVS Health, Booking Holdings and Altria Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: United Parcel Service, ServiceNow, CVS Health, Booking Holdings and Altria Group
Top Stock Reports for United Parcel Service, ServiceNow & CVS Health
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including United Parcel Service, Inc. (UPS), ServiceNow, Inc. (NOW), and CVS Health Corporation (CVS).
Here's Why You Should Retain Walgreens (WBA) Stock for Now
by Zacks Equity Research
Investors are optimistic about Walgreens (WBA), given the strong performance in the International segment and notable product launches.
CVS Health (CVS) Stock Moves -1.09%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $84.58, marking a -1.09% move from the previous day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $84.51, marking a +0.86% move from the previous day.
The Zacks Analyst Blog Highlights: Verizon, CVS Health, BHP Group, Autodesk and DISH Network
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Verizon, CVS Health, BHP Group, Autodesk and DISH Network
Top Stock Reports for Verizon, CVS Health & BHP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), CVS Health Corporation (CVS), and BHP Group (BHP).
CVS Health (CVS) Up 8.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quidel's (QDEL) QuickVue OTC COVID-19 Test Now Widely Available
by Zacks Equity Research
In-store and online availability of Quidel's (QDEL) QuickVue OTC COVID-19 Test is expected to meet the rising COVID-19 testing needs across the United States.